Table 3. Baseline characteristics in alcohol group.
Variables | N | Mean ± SD or frequency (%) | Median (range) |
---|---|---|---|
Sex (female/male) | 330 | 6 (1.8)/324 (98.2) | |
Age (years) | 330 | 54.04±8.45 | 51.97 (24.54–86.11) |
Major causes of admission | 330 | ||
UGIB | 25 (7.6) | ||
HE | 10 (3.0) | ||
Ascites | 228 (69.1) | ||
Jaundice | 16 (4.8) | ||
Weakness | 48 (14.5) | ||
Others | 3 (1.0) | ||
HCC | 330 | 17 (5.2) | |
Laboratory tests | |||
RBC (1012/L) | 293 | 3.12±0.79 | 3.17 (1.55–5.23) |
Hb (g/L) | 295 | 98.26±29.22 | 101.00 (46.00–158.00) |
WBC (1012/L) | 295 | 6.29±3.71 | 5.40 (1.20–22.50) |
PLT (109/L) | 293 | 115.77±49.50 | 109.00 (52.00–269.00) |
TBIL (ìmol/L) | 289 | 38.61±24.73 | 32.70 (8.30–158.00) |
ALB (g/L) | 287 | 29.81±5.16 | 29.40 (20.10–44.00) |
ALT (U/L) | 287 | 33.62±32.39 | 24.00 (7.00–373.00) |
AST (U/L) | 284 | 62.25±56.02 | 45.50 (9.00–513.00) |
ALP (U/L) | 287 | 151.51±77.00 | 132.00 (48.00–597.00) |
GGT (U/L) | 284 | 199.62±167.07 | 167.50 (20.00–780.00) |
BUN (mmol/L) | 265 | 8.22±7.75 | 5.68 (2.78–55.85) |
Cr (ìmol/L) | 264 | 93.94±82.64 | 68.40 (42.50–667.90) |
K (mmol/L) | 286 | 3.86±0.65 | 3.84 (1.40–5.60) |
Na (mmol/L) | 286 | 138.09±4.84 | 138.00 (121.00–151.00) |
PT (s) | 195 | 17.32±3.14 | 16.50 (11.90–24.60) |
APTT (s) | 195 | 39.08±4.86 | 39.20 (30.60–62.40) |
INR | 195 | 1.58±0.44 | 1.40 (1.03–2.84) |
Child-Pugh score | 191 | 9.22±2.24 | 9.00 (5.00–15.00) |
Child-Pugh class (A/B/C) | 191 | 16 (8.4)/91 (47.6)/84 (44.0) | |
MELD-score | 173 | 12.73±6.60 | 11.27 (0.05–35.00) |
ALBI-score | 287 | ‒0.247±0.701 | ‒0.210 (‒1.990–1.150) |
UGIB, upper gastrointestinal bleeding; HE, hepatic encephalopathy; HCC, hepatocellular carcinoma; RBC, red blood cell; Hb, hemoglobin; WBC, white blood cell; PLT, platelet; TBIL, total bilirubin; ALB, albumin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; GGT, gamma-glutamyl transpeptidase; BUN, blood urea nitrogen; Cr, creatinine; K, potassium ion; Na, sodium ion; PT, prothrombin time; APTT, activated partial thromboplastin time; INR, international normalized ratio; MELD, model for end stage liver disease; ALBI, albumin-bilirubin.